Australia Deep Brain Stimulation Devices Market Size & Outlook
Australia deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Australia deep brain stimulation devices market highlights
- The Australia deep brain stimulation devices market generated a revenue of USD 14.4 million in 2024 and is expected to reach USD 27.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.8% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Obsessive Compulsive Disorder (OCD) is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 14.4 million |
| Market revenue in 2030 | USD 27.9 million |
| Growth rate | 11.8% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.0% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.
Dystonia was the largest segment with a revenue share of 70.83% in 2024. Horizon Databook has segmented the Australia deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Australia deep brain stimulation devices market is expected to grow at a higher CAGR over the forecast period owing to increase in the prevalence of neurological disorders such as dystonia, epilepsy, and PD.
Moreover, such nonprofit organizations are initiating awareness programs for neurological diseases such as PD. Thus, such initiatives being undertaken by both government and nonprofit organizations are expected to boost the growth of Australia deep brain stimulation devices market.
The utilization of deep brain stimulation devices for epilepsy-related seizures has recently been approved in Australia and other countries. For instance, Medtronic Deep Brain Stimulation System for Epilepsy was approved by the FDA in April 2018.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia deep brain stimulation devices market size, by application, 2018-2030 (US$M)
Australia Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
